| ■ 영문 제목 : Global Hepatitis C Virus (HCV) Antiviral Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00122 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 97 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 C형 간염 바이러스 (HCV) 항바이러스제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (HCV 항체, HCV 바이럴 로드, HCV 유전자형)와 용도별 시장규모 (진단 센터, 병원, 가정용) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 C형 간염 바이러스 (HCV) 항바이러스제 시장 점유율 - 지역별 C형 간염 바이러스 (HCV) 항바이러스제 시장규모 - 주요지역의 종류별 시장규모 (HCV 항체, HCV 바이럴 로드, HCV 유전자형) - 주요지역의 용도별 시장규모 (진단 센터, 병원, 가정용) - 미주의 C형 간염 바이러스 (HCV) 항바이러스제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 C형 간염 바이러스 (HCV) 항바이러스제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 C형 간염 바이러스 (HCV) 항바이러스제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 C형 간염 바이러스 (HCV) 항바이러스제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 C형 간염 바이러스 (HCV) 항바이러스제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Roche Diagnostics, Abbott, Siemens, Qiagen, bioMérieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics, Biogate Laboratories, J.Mitra & Co. Ltd, Siemens Medical, General Biologicals - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Hepatitis C Virus (HCV) Antiviral will have significant change from previous year. By the most conservative estimates of global Hepatitis C Virus (HCV) Antiviral market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hepatitis C Virus (HCV) Antiviral market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis C Virus (HCV) Antiviral market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
HCV Antibody
HCV Viral Load
HCV Genotyping
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Diagnostic Centers
Hospitals
Home Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
1 Scope of the Report 2 Executive Summary 3 Hepatitis C Virus (HCV) Antiviral Market Size by Players 4 Hepatitis C Virus (HCV) Antiviral by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Hepatitis C Virus (HCV) Antiviral Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Hepatitis C Virus (HCV) Antiviral Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of HCV Antibody Table 3. Major Players of HCV Viral Load Table 4. Major Players of HCV Genotyping Table 5. Hepatitis C Virus (HCV) Antiviral Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type (2016-2021) Table 8. Hepatitis C Virus (HCV) Antiviral Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application (2016-2021) Table 11. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2019-2021E) Table 13. Hepatitis C Virus (HCV) Antiviral Key Players Head office and Products Offered Table 14. Hepatitis C Virus (HCV) Antiviral Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Hepatitis C Virus (HCV) Antiviral Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Regions 2016-2021 Table 19. Americas Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Country (2016-2021) Table 21. Americas Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type (2016-2021) Table 23. Americas Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application (2016-2021) Table 25. APAC Hepatitis C Virus (HCV) Antiviral Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Region (2016-2021) Table 27. APAC Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type (2016-2021) Table 29. APAC Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application (2016-2021) Table 31. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Country (2016-2021) Table 33. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type (2016-2021) Table 35. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Hepatitis C Virus (HCV) Antiviral Table 44. Key Application and Potential Industries of Hepatitis C Virus (HCV) Antiviral Table 45. Key Challenges of Hepatitis C Virus (HCV) Antiviral Table 46. Key Trends of Hepatitis C Virus (HCV) Antiviral Table 47. Global Hepatitis C Virus (HCV) Antiviral Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Hepatitis C Virus (HCV) Antiviral Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Hepatitis C Virus (HCV) Antiviral Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share Forecast by Application (2021-2026) Table 53. Roche Diagnostics Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 54. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product Offered Table 55. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Roche Diagnostics Main Business Table 57. Roche Diagnostics Latest Developments Table 58. Abbott Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 59. Abbott Hepatitis C Virus (HCV) Antiviral Product Offered Table 60. Abbott Main Business Table 61. Abbott Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Abbott Latest Developments Table 63. Siemens Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 64. Siemens Hepatitis C Virus (HCV) Antiviral Product Offered Table 65. Siemens Main Business Table 66. Siemens Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Siemens Latest Developments Table 68. Qiagen Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 69. Qiagen Hepatitis C Virus (HCV) Antiviral Product Offered Table 70. Qiagen Main Business Table 71. Qiagen Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Qiagen Latest Developments Table 73. bioMérieux Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 74. bioMérieux Hepatitis C Virus (HCV) Antiviral Product Offered Table 75. bioMérieux Main Business Table 76. bioMérieux Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. bioMérieux Latest Developments Table 78. Bio-Rad Laboratories Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 79. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product Offered Table 80. Bio-Rad Laboratories Main Business Table 81. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Bio-Rad Laboratories Latest Developments Table 83. Meridian Bioscience Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 84. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product Offered Table 85. Meridian Bioscience Main Business Table 86. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Meridian Bioscience Latest Developments Table 88. Vista Diagnostics Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 89. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Product Offered Table 90. Vista Diagnostics Main Business Table 91. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Vista Diagnostics Latest Developments Table 93. Biogate Laboratories Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 94. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product Offered Table 95. Biogate Laboratories Main Business Table 96. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Biogate Laboratories Latest Developments Table 98. J.Mitra & Co. Ltd Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 99. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product Offered Table 100. J.Mitra & Co. Ltd Main Business Table 101. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. J.Mitra & Co. Ltd Latest Developments Table 103. Siemens Medical Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 104. Siemens Medical Hepatitis C Virus (HCV) Antiviral Product Offered Table 105. Siemens Medical Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Siemens Medical Main Business Table 107. Siemens Medical Latest Developments Table 108. General Biologicals Details, Company Type, Hepatitis C Virus (HCV) Antiviral Area Served and Its Competitors Table 109. General Biologicals Hepatitis C Virus (HCV) Antiviral Product Offered Table 110. General Biologicals Main Business Table 111. General Biologicals Hepatitis C Virus (HCV) Antiviral Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. General Biologicals Latest Developments List of Figures Figure 1. Hepatitis C Virus (HCV) Antiviral Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type in 2020 Figure 7. Hepatitis C Virus (HCV) Antiviral in Diagnostic Centers Figure 8. Global Hepatitis C Virus (HCV) Antiviral Market: Diagnostic Centers (2016-2021) & ($ Millions) Figure 9. Hepatitis C Virus (HCV) Antiviral in Hospitals Figure 10. Global Hepatitis C Virus (HCV) Antiviral Market: Hospitals (2016-2021) & ($ Millions) Figure 11. Hepatitis C Virus (HCV) Antiviral in Home Use Figure 12. Global Hepatitis C Virus (HCV) Antiviral Market: Home Use (2016-2021) & ($ Millions) Figure 13. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application in 2020 Figure 14. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Player in 2020 Figure 15. Global Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Regions (2016-2021) Figure 16. Americas Hepatitis C Virus (HCV) Antiviral Market Size 2016-2021 ($ Millions) Figure 17. APAC Hepatitis C Virus (HCV) Antiviral Market Size 2016-2021 ($ Millions) Figure 18. Europe Hepatitis C Virus (HCV) Antiviral Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size 2016-2021 ($ Millions) Figure 20. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Country in 2020 Figure 21. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type in 2020 Figure 22. Americas Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application in 2020 Figure 23. United States Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Regions in 2020 Figure 27. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type in 2020 Figure 28. APAC Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application in 2020 Figure 29. China Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 33. India Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Country in 2020 Figure 36. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type in 2020 Figure 37. Europe Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application in 2020 Figure 38. Germany Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 39. France Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Market Share by Application in 2020 Figure 46. Egypt Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Hepatitis C Virus (HCV) Antiviral Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 52. APAC Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 53. Europe Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 55. United States Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 56. Canada Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 57. Mexico Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 58. Brazil Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 59. China Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 60. Japan Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 61. Korea Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 63. India Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 64. Australia Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 65. Germany Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 66. France Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 67. UK Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 68. Italy Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 69. Russia Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 70. Spain Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 71. Egypt Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 72. South Africa Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 73. Israel Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 74. Turkey Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Hepatitis C Virus (HCV) Antiviral Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 C형 간염 바이러스 (HCV) 항바이러스제 시장예측 2021년-2026년] (코드 : LPI-2201K00122) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 C형 간염 바이러스 (HCV) 항바이러스제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |